Top Institutional Investors

Qiming U.S. Ventures Management, LLC — 13F Holdings & Portfolio

CIK 1909617 · latest 13F-HR filed 2025-11-10

Backtest portfolio

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Loading holdings…
AUM

$55.6M

Long-equity book

Holdings

4

Distinct positions

Period

2025-09-30

Filed 2025-11-10

Q/Q Activity

+0 / −2 / ↑2 / ↓2

vs 2025-06-30

Firm Profile & Key People
Name Title / Status Ownership Type

Top Adds (vs prior quarter)

  • TOURMALINE BIO INC$23.6M +199.1%
  • KORRO BIO INC$13.0M +283.4%
Show all 2 →

Top Trims

  • JASPER THERAPEUTICS INC-$2.9M -57.1%
  • KEZAR LIFE SCIENCES INC-$56.4K -14.8%
Show all 2 →

New Positions

  • No new positions this quarter.
Show all 0 →

Exited Positions

  • VENTYX BIOSCIENCES INC$882.2K
  • HILLEVAX INC$741.5K
Show all 2 →
All Holdings

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 TOURMALINE BIO INC — 89157D105 $35.5M 63.76% 741,691 SH
2 KORRO BIO INC KRRO 500946108 $17.6M 31.68% 368,085 SH
3 JASPER THERAPEUTICS INC JSPR 471871202 $2.2M 3.97% 928,964 SH
4 KEZAR LIFE SCIENCES INC KZR 49372L209 $323.2K 0.58% 82,871 SH
Filing History
Period Filed AUM Holdings Accession
2025-09-30 2025-11-10 $55.6M 4 0001909617-25-000004
2025-06-30 2025-08-14 $23.6M 6 0001415889-25-021900